期刊文献+

慢性脑血流低灌注大鼠血和脑内β-淀粉样肽的变化 被引量:1

The Effects of Chronic Cerebral Hypoperfusion of the Content of β-amyloid Peptide in Rat’s Blood and Brain
在线阅读 下载PDF
导出
摘要 目的研究慢性脑血流低灌注对大鼠血和脑内β-淀粉样肽(β-amyloid peptide,Aβ)含量的影响。方法老年(10月龄)雄性SD大鼠双侧颈总动脉结扎,分别于手术后10d、30d、90d和180d进行Morris水迷宫实验;用放射免疫分析法检测血清、大脑皮质及海马的Aβ含量;用Western blot方法检测大脑皮质和海马的β-淀粉样肽前体蛋白(β-amyloid precursor protein,APP)的含量。结果Morris水迷宫实验显示,大鼠在术后30d、90d、180d均出现学习记忆功能下降,与对照组比较差异有统计学意义(P<0.05);血清Aβ水平在术后10d显著增高(P<0.01),30d、90d、180d血清Aβ水平仍高于对照组(P<0.05);术后90d和180d海马的Aβ和APP增高(P<0.05),180d皮质的Aβ和APP增高(P<0.05)。结论慢性脑血流低灌注引发大鼠脑及血中Aβ的升高,可能在阿尔茨海默病(Alzheimer’s disease,AD)早期发病过程中有重要意义。 Objective To investigate the changes of β-amyloid peptide(Aβ) in rats' blood and brain under the condition of chronic cerebral hypoperfusion. Methods Cerebral blood hypoperfusion rat model established by bilateral common carotid artery permanent ligation was used. Learning memory function were examined by Morris water maze. Radioimmunoassay and western blotting were employed to test the levels of Aβ and β-amyloid precursor protein (APP) in serum, cortex and hippocampal. Results The deficiency in learning-memory function began to appear from 1 m after hypoperfusion. Levels of Aβ in serum was significantly increased in each experimental group. Both APP and Aβ were increased from 3 m after hypoperfusion in hippocampal and the same changes occurred from 6m after hypoperfusion in cortex. Conclusion Chronic cerebral hypoperfusion can lead to increase of Aβ both in brain and blood which may play a very important role in early pathogenesis of Alzheimer's disease(AD).
出处 《首都医科大学学报》 CAS 2007年第2期234-238,共5页 Journal of Capital Medical University
基金 北京市教育委员会科技发展计划面上项目(200410025011)资助项目
关键词 慢性脑血流低灌注 阿尔茨海默病 Β-淀粉样肽 淀粉样前体蛋白 chronic cerebral hypoperfusion Alzheimer's disease β-amyloid peptide β-amyloid precursor protein
作者简介 通讯作者
  • 相关文献

参考文献12

  • 1Lee V M,Goedert M,Trojanowski J Q.Neurodegenerative tauopathies[J].Annu Rev Neurosci,2001,24:1121-1159.
  • 2Lee B C,Mintun M,Buckner R L,et al.Imaging of Alzheimer's disease[J].J Neuroimaging,2003,13:199-214.
  • 3de la Torre J C.Cerebral hypoperfusion,capillary degeneration,and development of Alzheimer disease[J].Alzheimer Dis Assoc Disord,2000,14(Supp11):S72-81.
  • 4de la Torre J C,Stefano G B.Evidence that Alzheimer's disease is a microvascular disorder:the role of constitutive nitric oxide[J].Brain Res Brain Res Rev,2000,34:119-136.
  • 5单培彦,朱琳,侯桂华,刘德宜,张超,高静.脑梗塞患者血清中β淀粉样蛋白的含量及其临床意义[J].山东大学学报(医学版),2005,43(4):353-355. 被引量:4
  • 6Kun T,Linda S H,Fred B.Platelet amyloid precursor protein processing:A bio-marker for Alzheimer's disease[J].J Neurol Sci,2006,240:53-58.
  • 7Deane R,Du Yan S,Submamaryan R K,et al.RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain[J].Nature Med,2003,9:907-913.
  • 8Caccamo A,Oddo S,Sugarman M C,et al.Age-and region-dependent alterations in Abeta-degrading enzymes:implications for Abeta-induced disorders[J].Neurobiol Aging,2005,26:645-654.
  • 9Nalivaevaa N N,Fisk L,Kochkina E G,et al.Effect of hypoxia/ischemia and hypoxic preconditioning/reperfusion on expression of some amyloid-degrading enzymes[J].Ann N Y Acad Sci,2004,1035:21-33.
  • 10Gong Y,Chang L,Viola K L,et al.Alzheimer's disease-affected brain:presence of oligomeric A beta Ligands (ADDLs) suggests a molecular basis for reversible memory loss[J].Proc Natl Acad Sci USA,2003,100:10417-10422.

二级参考文献8

  • 1Crawford F, Suo I, Fang C, et al. Characteristics of the in vitro vasoactivity of beta-amyloid peptide [J]. Exp Neurol, 1998, 150:159-168.
  • 2Koistinaho M, Kettunen MI, Holtzman DM, et al. Expression of human apolipoprotein E downregulates amyloid precursor protein-induced ischemic susceptibility[J].Stroke, 2002, 33(7):1 905-1 910.
  • 3Koistinaho J, Pyykonen I, Keinanen R, et al. Expression of beta-amyloid precursor protein mRNAs following transient focal ischemia[J]. Neuroreport, 1996, 7115:2 727.
  • 4Thal DR, Ghebremedhin E, Rub U, et al. Two types of sporadic cerebral amyloid angiopathy [J]. Neuropathol Exp Neurol, 2002, 61(3):282-293.
  • 5Allen JS, Murphy GM, Eng LF, et al. Alzheimer's disease: β- amyloid precursor protein mRNA expression in mononuclear blood cells[J]. Neuroscilett, 1991, 132:109-112.
  • 6Monning R, Konig G, Banati RB, et al. Alzheimer betaamyloid protein precursor in immunocompeyent cells[J].Biol Chem, 1992, 267:23 950-23 956.
  • 7Weller RO, Rreston SD. The spectrum of vascular disease in dementia from ischemia to amyloid angiopathy[J]. Adv Exp Med Biol, 2001, 487(2):111-122.
  • 8Yah SD, Chen X, Fu J, et al. RAGE and beta peptideneurotoxicity in Alzheimer's disease [J]. Nature, 1996,382:685-691.

共引文献3

同被引文献17

  • 1张洁,闫福岭.Alzheimer病的血管病因假设[J].国外医学(脑血管疾病分册),2004,12(12):918-921. 被引量:5
  • 2史伟雄,洪震.脑内β淀粉样蛋白清除的研究进展[J].国外医学(神经病学.神经外科学分册),2005,32(2):106-109. 被引量:3
  • 3鲁国,闫福岭.Alzheimer病与缺血性脑血管病相关性的研究进展[J].现代医学,2005,33(2):131-133. 被引量:1
  • 4李颖莉,赵炳让,秦勤.低密度脂蛋白受体相关蛋白与动脉粥样硬化的关系[J].中国分子心脏病学杂志,2003,3(3):167-173. 被引量:8
  • 5闫福岭,郑莹,洪震.脑缺血与Alzheimer病的老年斑[J].国际脑血管病杂志,2006,14(11):823-826. 被引量:3
  • 6Deane R, Du YS, Submamaryan RK, et al. RAGE mediates amyloid- beta peptide transport across the blood-brain barrier and accumulation in brain[J]. Nat Med, 2003, 9(7): 907-913.
  • 7Shibata M, Yamada S, Kumar SR, et al. Clearance of Alzheimer' s amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier[J]. J Clin Invest, 2000, 106(12) : 1489- 1499.
  • 8De TJ. Is Alzheimer' s disease a neurodegenerative or a vascular disorder? data, dogma, and dialectics I J]. Lancet Neurol, 2004, 3 (3) : 184-190.
  • 9Farkas E, De VR, Jansen SE, et al. Are Alzheimer' s disease, hypertension, and cerebrocapillary damage related [ J ].9 Neurobiol Aging, 2000, 21(2): 235-243.
  • 10Farkas E, Luiten PG, Bail F. Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion- related neurodegenerative diseases[J]. Brain Res Rev, 2007, 54( 1 ) : 162-180.

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部